The Fto Gene Regulates the Proliferation and Differentiation of Pre-Adipocytes in Vitro

Overview

Journal Nutrients

Date 2016 Feb 25

PMID 26907332

Citations 13

Authors

Yang Jiao

Jingying Zhang

Lunjie Lu

Jiaying Xu

Liqiang Qin

Affiliations

Soon will be listed here.

Abstract

The highly regulated differentiation and proliferation of pre-adipocytes play a key role in the initiation of obesity. Fat mass and obesity associated (FTO) is a novel gene strongly associated with the risk of obesity. A deficiency of FTO may cause growth retardation in addition to fat mass and adipocyte size reduction in vivo. To investigate the potential role of Fto gene on the proliferation and differentiation of pre-adipocytes, we generated Fto-knockdown and overexpressed 3T3-L1 cells. Using numerous proliferation assays our results suggest that Fto knockdown leads to suppression of proliferation, lower mitochondrial membrane potential, less cellular ATP, and decreased and smaller intracellular lipid droplets compared with controls (p < 0.05). Western blot analysis demonstrated that Fto knockdown can significantly suppress peroxisome proliferator-activated receptor gamma (PPARγ) and glucose transporter type 4 (GLUT4) expression and inhibit Akt phosphorylation. By contrast, overexpression of Fto had the opposing effect on proliferation, mitochondrial membrane potential, ATP generation, in vitro differentiation, Akt phosphorylation, and PPARγ and GLUT4 expression. Moreover, we demonstrated that Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, could inhibit phospho-Akt in Fto overexpressed 3T3-L1 cells. Taken together, the results suggest that Fto regulates the proliferation and differentiation of 3T3-L1 cells via multiple mechanisms, including PPARγ and PI3K/Akt signaling.

Citing Articles

Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity.

Uner B, Ergin A, Ansari I, Macit-Celebi M, Ansari S, Kahtani H Molecules. 2023; 28(20).

PMID: 37894594 PMC: 10609287. DOI: 10.3390/molecules28207115.

Anti-obesity effects of chlorogenic acid and caffeine- lipid nanoparticles through PPAR-γ/C/EBP-ɑ pathways.

Uner B, Macit Celebi M Int J Obes (Lond). 2023; 47(11):1108-1119.

PMID: 37596386 DOI: 10.1038/s41366-023-01365-7.

mA demethylase FTO regulate CTNNB1 to promote adipogenesis of chicken preadipocyte.

Li K, Huang W, Wang Z, Nie Q J Anim Sci Biotechnol. 2022; 13(1):147.

PMID: 36461116 PMC: 9716549. DOI: 10.1186/s40104-022-00795-z.

Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases.

Chen X, Wang J, Tahir M, Zhang F, Ran Y, Liu Z Cell Biosci. 2021; 11(1):147.

PMID: 34315538 PMC: 8314498. DOI: 10.1186/s13578-021-00661-x.

FTO inhibits UPR-induced apoptosis by activating JAK2/STAT3 pathway and reducing m6A level in adipocytes.

Shen Z, Liu P, Sun Q, Li Y, Acharya R, Li X Apoptosis. 2021; 26(7-8):474-487.

PMID: 34212271 DOI: 10.1007/s10495-021-01683-z.

References

Merkestein M, Laber S, McMurray F, Andrew D, Sachse G, Sanderson J . FTO influences adipogenesis by regulating mitotic clonal expansion. Nat Commun. 2015; 6:6792. PMC: 4410642. DOI: 10.1038/ncomms7792. View

Paxinou E, Weisse M, Chen Q, Souza J, Hertkorn C, Selak M . Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress. Proc Natl Acad Sci U S A. 2001; 98(20):11575-80. PMC: 58771. DOI: 10.1073/pnas.201293198. View

Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P . Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39(6):724-6. DOI: 10.1038/ng2048. View

Ahmadian M, Suh J, Hah N, Liddle C, Atkins A, Downes M . PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013; 19(5):557-66. PMC: 3870016. DOI: 10.1038/nm.3159. View

Jiao Y, Sun K, Zhao L, Xu J, Wang L, Fan S . Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1). Acta Pharmacol Sin. 2011; 33(2):250-60. PMC: 4010328. DOI: 10.1038/aps.2011.163. View

Tews D, Fischer-Posovszky P, Fromme T, Klingenspor M, Fischer J, Ruther U . FTO deficiency induces UCP-1 expression and mitochondrial uncoupling in adipocytes. Endocrinology. 2013; 154(9):3141-51. DOI: 10.1210/en.2012-1873. View

Wang N, Wang X, Shi M, Shi H, Yan X, Li H . LMO4 modulates proliferation and differentiation of 3T3-L1 preadipocytes. FEBS Lett. 2013; 587(18):3032-7. DOI: 10.1016/j.febslet.2013.07.033. View

Wong R, Sul H . Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr Opin Pharmacol. 2010; 10(6):684-91. PMC: 3092640. DOI: 10.1016/j.coph.2010.08.004. View

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

10.

Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Bruning J . Inactivation of the Fto gene protects from obesity. Nature. 2009; 458(7240):894-8. DOI: 10.1038/nature07848. View

11.

Butsch W . Obesity medications: what does the future look like?. Curr Opin Endocrinol Diabetes Obes. 2015; 22(5):360-6. DOI: 10.1097/MED.0000000000000192. View

12.

Cristancho A, Lazar M . Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011; 12(11):722-34. PMC: 7171550. DOI: 10.1038/nrm3198. View

13.

Ma X, Lee P, Chisholm D, James D . Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol (Lausanne). 2015; 6:1. PMC: 4311677. DOI: 10.3389/fendo.2015.00001. View

14.

Rutkowski J, Stern J, Scherer P . The cell biology of fat expansion. J Cell Biol. 2015; 208(5):501-12. PMC: 4347644. DOI: 10.1083/jcb.201409063. View

15.

McMorrow A, Connaughton R, Lithander F, Roche H . Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality. Proc Nutr Soc. 2014; 74(1):67-82. DOI: 10.1017/S002966511400158X. View

16.

Bravard A, Veilleux A, Disse E, Laville M, Vidal H, Tchernof A . The expression of FTO in human adipose tissue is influenced by fat depot, adiposity, and insulin sensitivity. Obesity (Silver Spring). 2013; 21(6):1165-73. DOI: 10.1002/oby.20110. View

17.

Hebert J, Allison D, Archer E, Lavie C, Blair S . Scientific decision making, policy decisions, and the obesity pandemic. Mayo Clin Proc. 2013; 88(6):593-604. PMC: 3759398. DOI: 10.1016/j.mayocp.2013.04.005. View

18.

Gregoire F . Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood). 2001; 226(11):997-1002. DOI: 10.1177/153537020122601106. View

19.

Zhao X, Yang Y, Sun B, Shi Y, Yang X, Xiao W . FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014; 24(12):1403-19. PMC: 4260349. DOI: 10.1038/cr.2014.151. View

20.

Zhou Y, Wang Z, Higa M, Newgard C, Unger R . Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci U S A. 1999; 96(5):2391-5. PMC: 26794. DOI: 10.1073/pnas.96.5.2391. View